AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Merck & Co., Inc. Director's Dealing 2021

May 7, 2021

284_dirs_2021-05-07_e2f2b03b-b48c-4f11-904d-d756650946c1.zip

Director's Dealing

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Organon & Co. (OGN)
CIK: 0001821825
Period of Report: 2021-05-07

Reporting Person: Merck & Co., Inc. (10% Owner)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	100	Direct